Physician

John R Holt, M.D.

According to 2025 Medicare claims, John Holt, M.D. (NPI: 1720283187) practices cardiology in the Elizabethtown, KY market, with the plurality of this provider's patient population coming from Hardin, KY. This provider's primary affiliated billing organization is BAPTIST HEALTH MEDICAL GROUP INC (NPI: 1093338527; TIN: 205497203) and primary practice location at 42701-2787. Holt is affiliated with the Baptist Health Care Partners, LLC (ACO ID: A2975), participating under the MSSP model.

Holt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,822 traditional Medicare patients, billed 4,930 HCPCS/CPT codes, and received $209,632 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,098 prescription claims across 995 beneficiaries totaling $1,124,686 in drug costs, led by Eliquis (Apixaban). 2015 DME data shows 30 claims. Open Payments data shows 64 records totaling $1,047. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $318,970 to $209,632. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $309,508 to $1,124,686. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,907	5,997	$318,970
2016	2,098	6,304	$328,702
2017	2,386	7,337	$371,086
2018	2,530	7,229	$358,466
2019	2,362	7,064	$380,148
2020	1,923	4,899	$229,371
2021	1,776	4,851	$247,657
2022	1,820	5,171	$235,643
2023	1,932	5,483	$246,083
2024	1,822	4,930	$209,632

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	488	4,898	$309,508
2016	568	6,361	$389,092
2017	621	6,504	$485,664
2018	743	7,199	$649,850
2019	776	7,309	$912,204
2020	771	7,804	$1,101,714
2021	757	6,330	$1,055,978
2022	800	5,039	$1,031,773
2023	911	6,183	$1,327,402
2024	995	6,098	$1,124,686

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	30	$2,370
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	827	940	$84
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	409	426	$49
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	150	479	$14
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	257	264	$13
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	695	877	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	604	32,307	$618,030
Entresto	Sacubitril/Valsartan	89	5,390	$119,024
Repatha Sureclick	Evolocumab	115	4,774	$92,923
Xarelto	Rivaroxaban	57	3,041	$54,997
Farxiga	Dapagliflozin Propanediol	65	2,887	$53,026

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	64	$1,047	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John R. Holt, M.D.?

Tedicare shows public-source Medicare data for John R. Holt, M.D. (NPI 1720283187), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John R. Holt, M.D. have ACO affiliation data?

John R. Holt, M.D. is shown with ACO affiliation data for Baptist Health Care Partners, LLC (MSSP, ACO ID A2975).

What billing organization is linked to John R. Holt, M.D.?

John R. Holt, M.D. is linked to BAPTIST HEALTH MEDICAL GROUP INC (billing NPI 1093338527) in the available physician profile data.

Does John R. Holt, M.D. have Open Payments data?

John R. Holt, M.D. has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.